Moderna asked the FDA to authorize its Covid-19 vaccine for children 6 months to 5 years. If regulators agree, vaccinations could begin by summer.
Shot has been tested for kids aged 6 months to 5 years, a group not yet eligible for vaccination in the U.S.
Children under five in the U.S. aren’t yet eligible for a Covid-19 vaccine after efforts to get the shots to market have hit setbacks. WSJ’s Peter Loftus explains what we know about the vaccines and when they might become available. Photo composite: Todd JohnsonModerna Inc. has asked U.S. health regulators to authorize the use of its Covid-19 vaccine in children ages 6 months to 5 years old.
The company said Thursday that it had submitted the request after a study showed the shot safely induced immune responses in the young age group.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Pfizer Asks FDA to Authorize Covid-19 Booster for 5- to 11-Year-OldsPfizer Inc. and partner BioNTech SE said earlier this month that a third shot safely generated a strong immune response in the youngsters.
Weiterlesen »
Pfizer requests FDA authorization for Covid-19 booster for kids 5 through 11Pfizer and BioNTech said Tuesday that they have submitted an application to the US Food and Drug Administration for emergency use authorization of a booster dose of Covid-19 vaccine for children 5 through 11.
Weiterlesen »
Pfizer asks FDA to clear COVID-19 booster shot for children ages 5 to 11Pfizer asked U.S. regulators for emergency-use authorization of a booster shot of its COVID-19 vaccine in children ages 5 to 11.
Weiterlesen »
Moderna to ask FDA to authorize Covid-19 vaccine for young kidsThe request comes a month after the drug company signaled its two-dose regimen generated immune protection in the youngest children comparable to young adults.
Weiterlesen »
Moderna Asks FDA to Approve Its COVID-19 Shot for Kids Under 6Moderna on Thursday asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a long-awaited move toward potentially opening shots for millions of tots by summer.
Weiterlesen »
Moderna asks FDA to authorize first COVID-19 vaccine for very young childrenThe company says a low-dose version of its vaccine triggers an immune response in children ages 6 months to less than 6 years equivalent to what has protected older children and adults.
Weiterlesen »